
GSK claimed the result was a first for an ADC aimed at the “B7-H3” protein, an increasingly popular target of late among cancer drugmakers.

GSK claimed the result was a first for an ADC aimed at the “B7-H3” protein, an increasingly popular target of late among cancer drugmakers.
Dubai, UAE — (ARAB NEWSWIRE) — As the UAE closes out H1 2026, the primary…
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…
News Five pharmaceutical companies, including Lundbeck, Orion Pharma, Recursion, Servier, and one undisclosed organization, have committed around 80% of their…
The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their booster doses…
News A San Francisco startup Epia Neuro launched today with a minimally invasive brain-computer interface (BCI) designed to help stroke…
On January 12, 2018, Endpoints News sponsored a breakfast panel at the 2018 JP Morgan Healthcare Conference (JPM18) in San…
Sign in to your account